Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Department of Medical Biotechnologies, University of Siena, Siena, Italy.
J Antimicrob Chemother. 2018 Sep 1;73(9):2388-2395. doi: 10.1093/jac/dky185.
To investigate the potential synergism of colistin in combination with N-acetylcysteine against Acinetobacter baumannii strains grown in planktonic phase or as biofilms.
Sixteen strains were investigated, including nine colistin-susceptible (MIC range 0.5-1 mg/L) and seven colistin-resistant (MIC range 16-256 mg/L) strains. Synergism of colistin in combination with N-acetylcysteine was investigated by chequerboard assays. The activity of colistin/N-acetylcysteine combinations was further evaluated by time-kill assays with planktonic cultures (three colistin-resistant strains and one colistin-susceptible strain) and by in vitro biofilm models (three colistin-resistant and three colistin-susceptible strains).
Chequerboard assays revealed a relevant synergism of colistin/N-acetylcysteine combinations with all colistin-resistant strains, whereas no synergism was observed with colistin-susceptible strains. Time-kill assays showed a concentration-dependent potentiation of colistin activity by N-acetylcysteine against colistin-resistant strains, with eradication of the culture by combinations of N-acetylcysteine at 8000 mg/L plus colistin at 2 or 8 mg/L. A static effect during the first 8 h of incubation was demonstrated with the colistin-susceptible strain exposed to 0.25 × MIC colistin plus 8000 mg/L N-acetylcysteine. A remarkable antibiofilm synergistic activity of 8 mg/L colistin plus 8000 mg/L N-acetylcysteine was demonstrated with all colistin-resistant and colistin-susceptible strains. The effects were greater with colistin-resistant strains (marked reduction of viable biofilm cells was observed at sub-MIC colistin concentrations).
N-acetylcysteine, at concentrations achievable by topical administration, was shown to revert the colistin-resistant phenotype in A. baumannii, and to exert a relevant activity against biofilms of colistin-susceptible and colistin-resistant A. baumannii strains.
研究黏菌素与 N-乙酰半胱氨酸联合应用对浮游期或生物膜期鲍曼不动杆菌的潜在协同作用。
共检测了 16 株菌,包括 9 株黏菌素敏感株(MIC 范围为 0.5-1mg/L)和 7 株黏菌素耐药株(MIC 范围为 16-256mg/L)。采用棋盘微量稀释法检测黏菌素与 N-乙酰半胱氨酸联合应用的协同作用。通过浮游培养(3 株黏菌素耐药株和 1 株黏菌素敏感株)和体外生物膜模型(3 株黏菌素耐药株和 3 株黏菌素敏感株)的时间杀伤试验进一步评价黏菌素/N-乙酰半胱氨酸联合应用的活性。
棋盘微量稀释法显示,黏菌素/N-乙酰半胱氨酸联合应用对所有黏菌素耐药株均具有显著的协同作用,而对黏菌素敏感株无协同作用。时间杀伤试验显示,N-乙酰半胱氨酸可增强黏菌素对黏菌素耐药株的浓度依赖性作用,黏菌素耐药株在 N-乙酰半胱氨酸 8000mg/L 联合黏菌素 2 或 8mg/L 时可被清除。黏菌素敏感株在接触 0.25×MIC 黏菌素和 8000mg/L N-乙酰半胱氨酸时,在孵育的前 8 小时显示出静态作用。还证实了 8mg/L 黏菌素联合 8000mg/L N-乙酰半胱氨酸对所有黏菌素耐药株和黏菌素敏感株具有显著的抗生物膜协同作用。对黏菌素耐药株的作用更大(在亚 MIC 黏菌素浓度下观察到活生物膜细胞的明显减少)。
在局部给药时可达到的浓度下,N-乙酰半胱氨酸可使鲍曼不动杆菌的黏菌素耐药表型逆转,并对黏菌素敏感和耐药的鲍曼不动杆菌菌株的生物膜发挥相关作用。